Tokyo, Japan

Makoto Ujihara


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Makoto Ujihara: A Pioneer in Renal Growth Promotion

Introduction: Makoto Ujihara, an inventive mind based in Tokyo, Japan, has made significant strides in the field of medical innovation. With a focus on enhancing renal health, Ujihara has contributed to the understanding of the effects of hormones on kidney growth and function. His groundbreaking patent reflects his dedication to advancing medical science.

Latest Patents: Ujihara's notable patent, titled "Renal Growth Promoter and Process for the Production of the Same," introduces a novel application of luteinizing hormone or its isoforms. The invention, which was previously unrecognized, reveals the hormone's potential to promote renal growth. This innovation is particularly promising for individuals facing diminished renal function or a reduction in renal cell numbers, providing a therapeutic avenue for activating kidney function through hormonal treatment.

Career Highlights: Ujihara is affiliated with the Calpis Food Industry Co., Ltd., where he has embarked on his journey as an inventor. His role at the company allows him to blend his research with practical applications in food and health industries. Ujihara's contributions to the field of medical innovation make him a significant figure in advancing therapeutic practices.

Collaborations: In his pursuit of innovation, Ujihara has collaborated with talented colleagues such as Kaoru Nomura and Kazutaka Ohmura. These partnerships have facilitated the development and refinement of his research, enabling a collaborative approach toward promoting renal health.

Conclusion: Makoto Ujihara exemplifies the spirit of innovation within the medical field. His patent on renal growth promotion highlights the intersection of hormone research and kidney health. As he continues to work with his colleagues at Calpis Food Industry Co., Ltd., his contributions are poised to make a lasting impact on renal therapies and patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…